FDA.reportPublic FDA data

Application 215939

Type
ANDA
Sponsor
ANNORA PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXCARBAZEPINEOXCARBAZEPINETABLET;ORAL150MGNoNo
002OXCARBAZEPINEOXCARBAZEPINETABLET;ORAL300MGNoNo
003OXCARBAZEPINEOXCARBAZEPINETABLET;ORAL600MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
31722-023OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
31722-023OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
31722-024OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
31722-024OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
31722-025OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
31722-025OxcarbazepineOxcarbazepineCamber Pharmaceuticals, Inc.ANDACurrent
60687-711OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent
60687-711OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent
60687-722OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent
60687-722OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent
60687-733OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent
60687-733OxcarbazepineOxcarbazepineAmerican Health PackagingANDACurrent